Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?

Medical Care
Eric C SchneiderArnold M Epstein

Abstract

Medicare managed care (MMC) plans may be better positioned to deliver preventive services than fee-for-service (FFS) insurers. We assessed whether beneficiaries in MMC plans were more likely than those in traditional FFS insurance to receive colorectal cancer (CRC) screening and whether type of insurance was associated with use of specific screening strategies. We studied 10,173 respondents to the 2000 Medicare Current Beneficiary Survey representing 24,394,204 US Medicare beneficiaries. We identified 4 CRC screening strategies: (1) interval-appropriate screening, (2) fecal occult blood testing (FOBT) within the past 2 years, (3) colonoscopy or sigmoidoscopy within the past 5 years, and (4) primary invasive screening (interval-appropriate colonoscopy or sigmoidoscopy without FOBT). Using a propensity score model to adjust for the nonrandom selection of insurance based on sociodemographic characteristics and other respondent-reported "care-seeking" variables, we compared the adjusted percentage of MMC and FFS beneficiaries screened using each CRC screening strategy. In this sample, 21.6% of Medicare beneficiaries were continuously enrolled in MMC, 61.3% had FFS with supplemental insurance, and 17.1% had FFS coverage alone. Just ...Continue Reading

References

Apr 27, 1995·The New England Journal of Medicine·J Blustein
Feb 12, 1998·Annals of Internal Medicine·D B Rubin
Dec 24, 1997·Journal of Community Health·S J WilliamsJ A Mayer
Mar 3, 1999·JAMA : the Journal of the American Medical Association·G F RileyR Ballard-Barbash
Oct 18, 2000·JAMA : the Journal of the American Medical Association·A L FrazierK M Kuntz
Oct 24, 2000·JAMA : the Journal of the American Medical Association·J Z AyanianA M Zaslavsky
Sep 27, 2001·JAMA : the Journal of the American Medical Association·E C SchneiderA M Epstein
Jan 5, 2002·The New England Journal of Medicine·David F Ransohoff, Robert S Sandler
Feb 13, 2002·Archives of Internal Medicine·Amnon Sonnenberg, Fabiola Delcò
Jan 31, 2003·Gastroenterology·Sidney WinawerUNKNOWN Gastrointestinal Consortium Panel
Mar 15, 2003·JAMA : the Journal of the American Medical Association·Brenda E SirovichSteven Woloshin
Oct 12, 2005·Archives of Internal Medicine·Ann S O'MalleyJeanne Mandelblatt
Mar 15, 2006·American Journal of Preventive Medicine·Carrie N KlabundeWilliam W Davis
Jun 17, 2006·American Journal of Preventive Medicine·Michael V MaciosekMichael J Goodman
Jun 17, 2006·American Journal of Preventive Medicine·Michael V MaciosekLeif I Solberg
Dec 21, 2006·JAMA : the Journal of the American Medical Association·Cary P GrossMary E Tinetti

❮ Previous
Next ❯

Citations

Dec 1, 2009·Cancer Causes & Control : CCC·Lee MobleyLuc Anselin
Apr 2, 2010·Journal of the National Cancer Institute·John Z Ayanian
Sep 8, 2010·International Journal of Health Geographics·Lee R MobleySujha Subramanian
Mar 6, 2013·Journal of Cancer·Mia Debarros, Scott R Steele
Nov 14, 2012·Journal of Women's Health·Ramzi G SalloumAndrea K Biddle
Jan 2, 2009·Digestive Diseases and Sciences·Michael T HalpernElizabeth M Ward
Sep 8, 2015·Journal of Epidemiology and Global Health·Sharmila ChatterjeePaul H Levine
Feb 2, 2010·American Journal of Preventive Medicine·Chyke A DoubeniRobert H Fletcher
Jul 5, 2012·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Lin FanKatia Noyes
Nov 19, 2011·Health Services Research·Lee Rivers MobleyLuc Anselin
May 25, 2012·Journal of the National Cancer Institute. Monographs·Joseph P MorrisseyJeanne Mandelblatt
Sep 9, 2008·Medical Care·Carrie N KlabundeMartin L Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.